Paclitaxel-associated reticulate hyperpigmentation: Report and review of chemotherapy-induced reticulate hyperpigmentation

doi:10.12998/wjcc.v4.i12.390

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 12

This Article

(386)

(403)

(0)

(13842)

(19)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Case Report

World J Clin Cases. Dec 16, 2016; 4(12): 390-400
Published online Dec 16, 2016. doi: 10.12998/wjcc.v4.i12.390

Full Size Figure Download Figure

Figure 2 Paclitaxel-associated reticulate hyperpigmentation on the lower extremities. Linear and net-like hyperpigmentation is noted on distant (A), intermediate (B and D) and closer (C) views of the right thigh (B and C) and right pretibial area (D).

Citation: Cohen PR. Paclitaxel-associated reticulate hyperpigmentation: Report and review of chemotherapy-induced reticulate hyperpigmentation. World J Clin Cases 2016; 4(12): 390-400
URL: https://www.wjgnet.com/2307-8960/full/v4/i12/390.htm
DOI: https://dx.doi.org/10.12998/wjcc.v4.i12.390

Cohen PR. Paclitaxel-associated reticulate hyperpigmentation: Report and review of chemotherapy-induced reticulate hyperpigmentation. World J Clin Cases 2016; 4(12): 390-400 [PMID: 28035312 DOI: 10.12998/wjcc.v4.i12.390]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.